Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

June 20, 2022

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

Novel humanized mouse model of posterior fossa A ependymoma

June 20, 2022

Magmas inhibition as new therapeutic strategy in medulloblastoma

June 20, 2022

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

June 20, 2022

OR-449 differentially regulates sulfation pathway genes in ACC

June 17, 2022

Merck & Co. patents new GTPase KRAS inhibitors

June 17, 2022

Peptide-based radiopharmaceutical with reduced kidney and healthy tissue uptake

June 17, 2022

Aqemia and Sanofi extend collaboration to use AI technology to optimize molecules to treat cancer

June 16, 2022

Dunad Therapeutics and collaborators present new GTPase KRAS inhibitors

June 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...